Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $56.43 USD
Change Today -0.56 / -0.98%
Volume 2.0M
As of 9:59 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jerry T. Jackson

AgeTotal Calculated CompensationThis person is connected to 19 board members in 4 different organizations across 6 different industries.

See Board Relationships
73--

Background*

Mr. Jerry T. Jackson served as an Executive Vice President of Merck & Co., Inc., from 1993 to 1995. During this time, Mr. Jackson had responsibility for Merck's International Human Health Division, Worldwide Human Vaccines, the AgVet Division, Astra/Merck U.S. Operations and Worldwide Marketing. During 1993, Mr. Jackson served as President of the Worldwide Human Health Division. He served as Senior Vice President of Merck from 1991 to 1992 responsible for Merck's Specialty ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

1996-Present
Director
1997-Present
Director
2001-Present
Director
2002-Present
Director and Chairman of Nominating & Corporate Governance Committee

Education*

BA
University of New Mexico

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $56.43 USD -0.56

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.2M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Jean-Paul Agon Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee
L'Oreal SA
€4.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.